CHAPTER 3 Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma Maria J. De Herdt*, Stefan M. Willems*, Berdine van der Steen**, Rob Noorlag**, Esther I. Verhoef, Geert J.L.H. van Leenders, Robert J.J. van Es, Senada Koljenović, Robert J. Baatenburg de Jong***, Leendert H.J. Looijenga*** *, **, *** The authors contributed equally to this work as co-first, second and final authors respectively Oncotarget 2016;7:13167-81.
RkJQdWJsaXNoZXIy MTk4NDMw